Denileukin diftitox Completed Phase 2 Trials for Chronic Lymphocytic Leukemia (CLL) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00055146 | Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) |